The company has announced that it will not be selling any of its common stock as part of the current prospectus. Consequently, it will not receive any financial proceeds from stock sales conducted by its selling stockholders. This decision means the company's direct financial position remains unaffected by the transactions outlined in this prospectus.
The selling stockholders will be the recipients of any proceeds generated through the sale of the company's stock. The company has clarified that their participation in this prospectus is limited to facilitating these sales rather than acting as a direct beneficiary. Investors should note that the company's financial outlook, independent of these stock sales, will remain unchanged as a result of this arrangement.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 1 analysts, the average target price for Surrozen Inc (SRZN, Financial) is $32.00 with a high estimate of $32.00 and a low estimate of $32.00. The average target implies an upside of 217.46% from the current price of $10.08. More detailed estimate data can be found on the Surrozen Inc (SRZN) Forecast page.
Based on the consensus recommendation from 1 brokerage firms, Surrozen Inc's (SRZN, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
